Update in asthma 2008

American Journal of Respiratory and Critical Care Medicine

Volumn 179, Issue 10, 2009, Pages 869-874

  Moore, Wendy C ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ARGINASE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BIOLOGICAL MARKER; CHLOROFLUOROCARBON; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID DERIVATIVE; DEXAMETHASONE; FLUORINATED HYDROCARBON; IPRATROPIUM BROMIDE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LIPOXIN; LONG ACTING DRUG; METHACHOLINE; MONTELUKAST; PLACEBO; PREDNISONE; SALMETEROL; SHORT ACTING DRUG; TIOTROPIUM BROMIDE; ZAFIRLUKAST; ZILEUTON;

ADD ON THERAPY; AIRWAY OBSTRUCTION; ASTHMA; ATOPY; BEHAVIOR CHANGE; BODY MASS; BRONCHIOLITIS; BRONCHOSPASM; CHILD HOSPITALIZATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CLUSTER ANALYSIS; COLD AIR; CORTICOSTEROID THERAPY; DISEASE EXACERBATION; DRUG INDICATION; DRUG MEGADOSE; DRUG SAFETY; EMERGENCY CARE; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVITY; EOSINOPHIL COUNT; EOSINOPHILIA; HIGH RISK POPULATION; HUMAN; INFLAMMATION; LOW DRUG DOSE; LUNG LAVAGE; LUNG VOLUME; MATHEMATICAL MODEL; METERED DOSE INHALER; MODERATE PERSISTENT ASTHMA; MONOTHERAPY; MOOD CHANGE; MORTALITY; NONHUMAN; NOSE MUCUS; OBESITY; ONSET AGE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROVOCATION TEST; RESPIRATORY TRACT INFECTION; REVIEW; RHINOVIRUS; RISK FACTOR; SIDE EFFECT; SMOKE; SMOKING; SMOOTH MUSCLE FIBER; SPUTUM; STATISTICAL MODEL; STROKE; SUICIDAL BEHAVIOR; SUICIDAL IDEATION; TREATMENT DURATION; VIRUS INFECTION; WHEEZING;

ANTI-ASTHMATIC AGENTS; ASTHMA; HUMANS;

EID: 65649116231     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200902-0290UP     Document Type: Review

References (71)

1. Moore WC. Update in Asthma 2007. Am J Respir Crit Care Med 2008;177:1068-1073.
2. National Asthma Education and Prevention Program. Expert Panel Report 3: guidelines for the diagnosis and management of asthma. Bethesda, MD: National Institutes of Health; National Heart, Lung, and Blood Institute; 2007:No. 07-4051. [Accessed 25 Jan 2009]. Available from: http://www.nhlbi.nih.gov/ guidelines/asthma/asthgdln.htm.
3. Haldar P, Pavord ID, Shaw DE, Berry MA, Thomas M, Brightling CE, Wardlaw AJ, Green RH. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med 2008;178:218-224.
4. Jackson DJ, Gangnon RE, Evans MD, Roberg KA, Anderson EL, Pappas TE, Printz MC, Lee W, Shult PA, Reisdorf E, et al. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med 2008;178:667-672.
5. Bacharier LB, Phillips BR, Zeiger RS, Szefler SJ, Martinez FD, Lemanske RF, Sorkness CA, Bloomberg GR, Morgan WJ, Paul IM, et al.; Childhood Asthma Research and Education Network of the National Heart, Lung, and Blood Institute. Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing. J Allergy Clin Immunol 2008;122:1127-1135.
6. Tantisira KG, Colvin R, Tonascia J, Strunk RC, Weiss ST, Fuhlbrigge AL; for the Childhood Asthma Management Program Research Group. Airway responsiveness in mild to moderate childhood asthma: sex influences on the natural history. Am J Respir Crit Care Med 2008;178:325-331.
7. Wu P, Dupont WD, Griffin MR, Carroll KN, Mitchel EF, Gebretsadik T, Hartert TV. Evidence of a causal role of winter virus infection during infancy on early childhood asthma. Am J Respir Crit Care Med 2008;178:1123-1129.
8. Sutherland TJT, Cowan JO, Taylor DR. Dynamic hyperinflation with bronchoconstriction: differences between obese and nonobese women with asthma. Am J Respir Crit Care Med 2008;177:970-975.
9. Sutherland TJT, Cowan JO, Young S, Goulding A, Grant AM, Williamson A, Brassett K, Herbison GP, Taylor DR. The association between obesity and asthma: interactions between systemic and airway inflammation. Am J Respir Crit Care Med 2008;178:469-475.
10. Sutherland ER, Goleva E, Strand M, Beuther DA, Leung DYM. Body mass and glucocorticoid response in asthma. Am J Respir Crit Care Med 2008;178:682-687.
11. Islam T, McConnell R, Gauderman WJ, Avol E, Peters JM, Gilliland FD. Ozone, oxidant defense genes, and risk of asthma during adolescence. Am J Respir Crit Care Med 2008;177:388-395.
12. Galanter J, Choudhry S, Eng C, Nazario S, Rodríguez-Santana JR, Casal J, Torres-Palacios A, Salas J, Chapela R, Watson HG, et al. ORMDL3 gene is associated with asthma in three ethnically diverse populations. Am J Respir Crit Care Med 2008;177:1194-1200.
13. Sharma M, Batra J, Mabalirajan U, Sharma S, Nagarkatti R, Aich J, Sharma SK, Niphadkar PV, Ghosh B. A genetic variation in inositol polyphosphate 4 phosphatase a enhances susceptibility to asthma. Am J Respir Crit Care Med 2008;177:712-719.
14. Vergara C, Tsai YJ, Grant AV, Rafaels N, Gao L, Hand T, Stockton M, Campbell M, Mercado D, Faruque M, et al. Gene encoding duffy antigen/receptor for chemokines is associated with asthma and IgE in three populations. Am J Respir Crit Care Med 2008;178:1017-1022.
15. Hunninghake GM, Lasky-Su J, Soto-Quirós ME, Avila L, Liang C, Lake SL, Hudson TJ, Spesny M, Fournier E, Sylvia JS, et al. Sex-stratified linkage analysis identifies a female-specific locus for IgE to cockroach in Costa Ricans. Am J Respir Crit Care Med 2008;177:830-836.
16. Schedel M, Pinto LA, Schaub B, Rosenstiel P, Cherkasov D, Cameron L, Klopp N, Illig T, Vogelberg C, Weiland SK, et al. IRF-1 gene variations influence IgE regulation and atopy. Am J Respir Crit Care Med 2008;177:613-621.
17. Litonjua AA, Lasky-Su J, Schneiter K, Tantisira KG, Lazarus R, Klanderman B, Lima JJ, Irvin CG, Peters SP, Hanrahan JP, et al. ARG1 is a novel bronchodilator response gene: screening and replication in four asthma cohorts. Am J Respir Crit Care Med 2008;178:688-694.
18. Miller RL, Ho S. Environmental epigenetics and asthma: current concepts and call for studies. Am J Respir Crit Care Med 2008;177:567-573.
19. Hoppin JA, Umbach DM, London SJ, Henneberger PK, Kullman GJ, Alavanja MCR, Sandler DP. Pesticides and atopic and nonatopic asthma among farm women in the agricultural health study. Am J Respir Crit Care Med 2008;177:11-18.
20. Willers SM, Wijga AH, Brunekreef B, Kerkhof M, Gerritsen J, Hoekstra MO, De Jongste JC, Smit HA. Maternal food consumption during pregnancy and the longitudinal development of childhood asthma. Am J Respir Crit Care Med 2008;178:124-131.
21. Kozyrskyja AL, Mai XM, McGrath P, HayGlass KT, Becker AB, MacNeil B. Continued exposure to maternal distress in early life is associated with an increased risk of childhood asthma. Am J Respir Crit Care Med 2008;177:142-147.
22. Pogson ZEK, Antoniak MD, Pacey SJ, Lewis SA, Britton JR, Fogarty AW. Does a low sodium diet improve asthma control? A randomized controlled trial. Am J Respir Crit Care Med 2008;178:132-138.
23. Wells K, Pladevall M, Peterson EL, Campbell J, Wang M, Lanfear DE, Williams LK. Race-ethnic differences in factors associated with inhaled steroid adherence among adult with asthma. Am J Respir Crit Care Med 2008;178:1194-1201.
24. Cohen RT, Canino GJ, Bird HR, Celedón JC. Violence, abuse, and asthma in Puerto Rican children. Am J Respir Crit Care Med 2008;178:453-459.
25. Schaumann F, Müller M, Braun A, Luettig B, Peden DB, Hohlfeld JM, Krug N. Endotoxin augments myeloid dendritic cell influx into the airways in patients with allergic asthma. Am J Respir Crit Care Med 2008;177:1307-1313.
26. Turato G, Barbato A, Baraldo S, Zanin ME, Bazzan E, Oliani KL, Calabrese F, Panizzolo C, Snijders D, Maestrelli P, et al. Nonatopic children with multitrigger wheezing have airway pathology comparable to atopic asthma. Am J Respir Crit Care Med 2008;178:476-482.
27. Panettieri RA Jr, Kotlikoff MI, Gerthoffer WT, Hershenson MB, Woodruff PG, Hall IP, Banks-Schlegel S. Airway smooth muscle in bronchial tone, inflammation, and remodeling: basic knowledge to clinical relevance. Am J Respir Crit Care Med 2008;177:248-252.
28. Regamey N, Ochs M, Hilliard TN, Mühlfeld C, Cornish N, Fleming L, Saglani S, Alton EWFW, Bush A, Jeffery PK, et al. Increased airway smooth muscle mass in children with asthma, cystic fibrosis, and non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med 2008;177:837-843.
29. Simcock DE, Kanabar V, Clarke GW, Mahn K, Karner C, O'Connor BJ, Lee TH, Hirst SJ. Induction of angiogenesis by airway smooth muscle from patients with asthma. Am J Respir Crit Care Med 2008;178:460-468.
30. Kariyawasam HH, Xanthou G, Barkans J, Aizen M, Kay AB, Robinson DS. Basal expression of bone morphogenetic protein receptor is reduced in mild asthma. Am J Respir Crit Care Med 2008;177:1074-1081.
31. Gauvreau GM, Boulet LP, Cockcroft DW, Baatjes A, Cote J, Deschesnes F, Davis B, Strinich T, Howie K, Duong M, et al. Antisense therapy against CCR3 and the common beta chain attenuates allergen-induced eosinophilic responses. Am J Respir Crit Care Med 2008;177:952-958.
32. Wos M, Sanak M, Soja J, Olechnowicz H, Busse WW, Szczeklik A. The presence of rhinovirus in lower airways of patients with bronchial asthma. Am J Respir Crit Care Med 2008;177:1082-1089.
33. Wang C, Huang C, Lin H, Lee K, Lin S, Liu C, Huang K, Ko Y, Chung KF, Kuo H. Increased circulating fibrocytes in asthma with chronic airflow obstruction. Am J Respir Crit Care Med 2008;178:583-591.
34. 4 receptor expression are decreased in severe asthma. Am J Respir Crit Care Med 2008;178:574-582.
35. Lara A, Khatri SB, Wang Z, Comhair SAA, Xu W, Dweik RA, Bodine M, Levison BS, Hammel J, Bleecker E, et al.; National Heart, Lung, and Blood Institute's Severe Asthma Research Program. Alterations of the arginine metabolome in asthma. Am J Respir Crit Care Med 2008;178:673-681.
36. Maarsingh H, Zuidhof AB, Bos IST, Van Duin M, Boucher J, Zaagsma J, Meurs H. Arginase inhibition protects against allergen-induced airway obstruction, hyperresponsiveness, and inflammation. Am J Respir Crit Care Med 2008;178:565-573.
37. Bates JHT, Cojocaru A, Haverkamp HC, Rinaldi LM, Irvin CG. The synergistic interactions of allergic lung inflammation and intratracheal cationic protein. Am J Respir Crit Care Med 2008;177:261-268.
38. Pantano C, Ather JL, Alcorn JF, Poynter ME, Brown AL, Guala AS, Beuschel SL, Allen GB, Whittaker LA, Bevelander M, et al. Nuclear factor-κB activation in airway epithelium induces inflammation and hyperresponsiveness. Am J Respir Crit Care Med 2008;177:959-969.
39. Lee KS, Kim SR, Park SJ, Min KH, Lee KY, Choe YH, Park SY, Chai OH, Zhang X, Song CH, et al. Mast cells can mediate vascular permeability through regulation of the PI3K-HIF-1α-VEGF axis. Am J Respir Crit Care Med 2008;178:787-797.
40. Pitchford SC, Momi S, Baglioni S, Casali L, Giannini S, Rossi R, Page CP, Gresele P. Allergen induces the migration of platelets to lung tissue in allergic asthma. Am J Respir Crit Care Med 2008;177:604-612.
41. Simoes DCM, Vassilakopoulos T, Toumpanakis D, Petrochilou K, Roussos C, Papapetropoulos A. Angiopoietin-1 protects against airway inflammation and hyperreactivity in asthma. Am J Respir Crit Care Med 2008;177:1314-1321.
42. Zhou J, Wolf CR, Henderson CJ, Cai Y, Board PG, Foster PS, Webb DC. Glutathione transferase P1: an endogenous inhibitor of allergic responses in a mouse model of asthma. Am J Respir Crit Care Med 2008;178:1202-1210.
43. Fattouh R, Midence NG, Arias K, Johnson JR, Walker TD, Goncharova S, Souza KP, Gregory RC Jr, Lonning S, Gauldie J, et al. Transforming growth factor-β regulates house dust mite-induced allergic airway inflammation but not airway remodeling. Am J Respir Crit Care Med 2008;177:593-603.
44. Southam DS, Ellis RE, Wattie J, Glass W, Inman MD. Goblet cell rebound and airway dysfunction with corticosteroid withdrawal in a mouse model of asthma. Am J Respir Crit Care Med 2008;178:1115-1122.
45. Wakashin H, Hirose K, Maezawa Y, Kagami S, Suto A, Watanabe N, Saito Y, Hatano M, Tokuhisa T, Iwakura Y, et al. IL-23 and Th17 cells enhance Th2-cell-mediated eosinophilic airway inflammation in mice. Am J Respir Crit Care Med 2008;178:1023-1032.
46. Wu Q, Martin RJ, LaFasto S, Efaw BJ, Rino JG, Harbeck RJ, Chu HW. Toll-like receptor 2 down-regulation in established mouse allergic lungs contributes to decreased mycoplasma clearance. Am J Respir Crit Care Med 2008;177:720-729.
47. Busse WW, Israel E, Nelson HS, Baker JW, Charous BL, Young DY, Vexler V, Shames RS; Daclizumab Asthma Study Group. Daclizumab improves asthma control in patients with moderate to severe persistent asthma: a randomized, controlled trial. Am J Respir Crit Care Med 2008;178:1002-1008.
48. Simpson JL, Powell H, Boyle MJ, Scott RJ, Gibson PG. Clarithromycin targets neutrophilic airway inflammation in refractory asthma. Am J Respir Crit Care Med 2008;177:148-155.
49. Montreal Protocol. September 16, 1987, S. Treaty Doc. No. 10, 100th Cong., 1st sess., 26 I. L. M. 1541 (1987).
50. US Food and Drug Administration. Final minutes for December 10 and 11, 2008 Safety Advisory Meeting. Available from: http://www.fda.gov/ohrms/dockets/ ac/cder08.html#PulmonaryAllergy (accessed February 17, 2009)
51. US Food and Drug Administration. Center for drug evaluation and research. early communication about an ongoing safety review of montelukast (singulair). [Accessed February 17, 2009.] Available from: http://www.fda.gov/cder/drug/ early-comm/montelukast.htm
52. US Food and Drug Administration. Center for drug evaluation and research. update of safety review follow-up to the March 27, 2008 Communication about the Ongoing Safety Review of Montelukast (Singulair). [Accessed February 17, 2009.] Available from: http://www.fda.gov/cder/drug/early-comm/montelukast-200901.htm.
53. US Food and Drug Administration. Center for Drug Evaluation and Research. Early Communication about an Ongoing Safety Review of Tiotropium. [Accessed February 17, 2009.] Available from: http://www.fda.gov/cder/drug/early-comm/ tiotropium.htm.
54. Nelson HS, Weiss ST, Bleecker ER, Yancey SW, Dorinsky PM; SMART Study Group. The salmeterol multicenter asthma research trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 2006;129:15-26. (Pubitemid 43265239)
55. Salpeter SR, Buckley NS, Ormiston TM, Salpeter EE. Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths. Ann Intern Med 2006;144:904-912. (Pubitemid 46768131)
56. National Asthma Education and Prevention Program. Expert Panel Report 2 Guidelines for the diagnosis and management of asthma. Bethesda, MD: National Institutes of Health; National Heart, Lung, and Blood Institute; 1997:No. 97-4051. [Accessed 25 Jan 2009.] Available at http://www.nhlbi.nih.gov/ guidelines/asthma/asthgdln.htm.
57. National Asthma Education and Prevention Program. Expert Panel Report: Guidelines for the diagnosis and management of asthma, Update on Selected Topics Bethesda, MD: National Institutes of Health; National Heart, Lung, and Blood Institute; 2002. [Accessed 25 Jan 2009.] Available at http://www.nhlbi.nih.gov/ guidelines/asthma/asthgdln.htm.
58. Jaeschke R, O'Byrne PM, Mejza F, Nair P, Lesniak W, Brozek J, Thabane L, Cheng J, Schünemann HJ, Sears MR, et al. The safety of long-acting β-agonists among patients with asthma using inhaled corticosteroids: systematic review and metaanalysis. Am J Respir Crit Care Med 2008;178:1009-1016.
59. Batemen E, Nelson H, Bousquet J, Kral K, Sutton L, Ortega H, Yancey S. Meta-analysis: effects of adding salmeterol to inhaled corticosteroids on serious asthma-related events. Ann Intern Med 2008;149:56-57.
60. O'Byrne P, Parameswaran K. Pharmacological management of mild or moderate persistent asthma. Lancet 2006;368:794-803. (Pubitemid 44279057)
61. Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M for the UPLIFT investigators. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008;359:1543-1554.
62. Singh S, Loke YK, Furberg CD. Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease. JAMA 2008;300:1439-1450.
63. Lee TA, Pickard AS, Au DH, Bartle B, Weiss KB. Risk of death associated with medications for recently diagnosed chronic obstructive pulmonary disease. Ann Intern Med 2008;149:380-390.
64. Green RH, Brightling CE, McKenna S, Hargadon B, Parker D, Bradding P, Wardlaw AJ, Pavord ID. Asthma exacerbations and sputum eosinophil counts: a randomized controlled trial. Lancet 2002;360:1715-1721. (Pubitemid 35447900)
65. Beuther DA, Sutherland ER. Overweight, obesity and incident asthma: a meta-analysis of prospective epidemiologic studies. Am J Respir Crit Care Med 2007;175:661-666.
66. Castro-Rodriguez JA, Holberg CJ, Wright AL, Martinez FD. A clinical index to define risk of asthma in young children with recurrent wheezing. Am J Respir Crit Care Med 2000;162:1403-1406.
67. Guilbert W, Morgan WJ, Zeiger RS, Mauger DT, Boehmer SJ, Szefler SJ, Bacharier LB, Lemanske RF, Stunk RC, Allen DB, et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma (PEAK study). N Engl J Med 2006;354:1985-1997.
68. Panickar J, Lakhanpaul M, Lambert PC, Kenia P, Stephenson T, Smyth A, Grigg J. Oral prednsiolone for preschool children with actue vius-induced wheezing. N Engl J Med 2009;360:329-338.
69. Ducharme FM, Lemire C, Noya FJD, Davis GM, Alos N, Lebland H, Savdie C, Collet JP, Khomenko L, Rivard G, et al. Preemptive use of high-dose fluticasone for virus-induced wheezing in young children. N Engl J Med 2009;360:339-353.
70. Bisgaard H, Hermansen MN, Loland L, Halkjaer LB, Buchvald F. Intermittent inhaled corticosteroids in infants with episodic wheezing (PAC study). N Engl J Med 2006;354:1998-2005.
71. Murray CS, Woodcock A, Langley SJ, Morris J, Custivic A; IFWIN Study Team. Secondary prevention of asthma by the use of inhaled fluticasone propionate in wheezy infants (IFWIN): double-blind, randomized, controlled study. Lancet 2006;368:754-762. (Pubitemid 44294820)